Hansen M - Search Results

1

High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.

Herrstedt J, Hannibal J, Hallas J, Andersen E, Laursen LC, Hansen M. Herrstedt J, et al. Among authors: hansen m. Ann Oncol. 1991 Mar;2(3):223-7. doi: 10.1093/oxfordjournals.annonc.a057911. Ann Oncol. 1991. PMID: 2043493 Free article. Clinical Trial.

2

Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer.

Herrstedt J, Sigsgaard T, Handberg J, Schousboe BM, Hansen M, Dombernowsky P. Herrstedt J, et al. Among authors: hansen m. J Clin Oncol. 1997 Apr;15(4):1690-6. doi: 10.1200/JCO.1997.15.4.1690. J Clin Oncol. 1997. PMID: 9193370 Clinical Trial.

3

Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study.

Nielsen D, Dombernowsky P, Skovsgaard T, Jensen J, Andersen E, Engelholm SA, Hansen M. Nielsen D, et al. Among authors: hansen m. Ann Oncol. 1990 Jul;1(4):275-80. doi: 10.1093/oxfordjournals.annonc.a057748. Ann Oncol. 1990. PMID: 2265137 Free article. Clinical Trial.

4

Dose-finding study of oral metopimazine.

Herrstedt J, Sigsgaard T, Angelo HR, Kampmann JP, Hansen M. Herrstedt J, et al. Among authors: hansen m. Support Care Cancer. 1997 Jan;5(1):38-43. doi: 10.1007/BF01681960. Support Care Cancer. 1997. PMID: 9010988 Clinical Trial.

5

Combination chemotherapy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens.

Osterlind K, Hansen M, Hirsch FR, Dombernowsky P, Sörenson S, Pedersen AG, Hansen HH. Osterlind K, et al. Among authors: hansen hh, hansen m. Ann Oncol. 1991 Jan;2(1):41-6. doi: 10.1093/oxfordjournals.annonc.a057823. Ann Oncol. 1991. PMID: 1848996 Free article. Clinical Trial.

6

New cytostatic drugs in ovarian cancer.

Hansen HH, Eisenhauer EA, Hansen M, Neijt JP, Piccart MJ, Sessa C, Thigpen JT. Hansen HH, et al. Among authors: hansen m. Ann Oncol. 1993;4 Suppl 4:63-70. doi: 10.1093/annonc/4.suppl_4.s63. Ann Oncol. 1993. PMID: 7906138 Review.

7

Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.

Lassen U, Kristjansen PE, Osterlind K, Bergman B, Sigsgaard TC, Hirsch FR, Hansen M, Dombernowsky P, Hansen HH. Lassen U, et al. Among authors: hansen hh, hansen m. Ann Oncol. 1996 Apr;7(4):365-71. doi: 10.1093/oxfordjournals.annonc.a010603. Ann Oncol. 1996. PMID: 8805928 Free article. Clinical Trial.

8

High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease.

Lund B, Hansen M, Hansen OP, Hansen HH. Lund B, et al. Among authors: hansen op, hansen hh, hansen m. J Clin Oncol. 1989 Oct;7(10):1469-73. doi: 10.1200/JCO.1989.7.10.1469. J Clin Oncol. 1989. PMID: 2674334 Clinical Trial.

9

A randomized study of sequential versus alternating combination chemotherapy in advanced ovarian carcinoma.

Lund B, Hansen M, Hansen HH, Thomsen HK, Sørensen BL, Nielsen NC, Lundvall F. Lund B, et al. Among authors: hansen hh, hansen m. Ann Oncol. 1990;1(2):134-40. doi: 10.1093/oxfordjournals.annonc.a057691. Ann Oncol. 1990. PMID: 2127690 Free article. Clinical Trial.

10

Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease.

Lund B, Hansen M, Hansen OP, Hansen HH. Lund B, et al. Among authors: hansen op, hansen hh, hansen m. J Clin Oncol. 1990 Jul;8(7):1226-30. doi: 10.1200/JCO.1990.8.7.1226. J Clin Oncol. 1990. PMID: 2113570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,039 results

Search Page